Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

CANCER GENOMICS

Form follows function in cancer genomes

Nature Cancer volume 3, pages 905–906 (2022)Cite this article

Subjects

Structural variants (SVs), such as copy-number alterations, rearrangements and aneuploidies, are common somatic changes in cancer genomes and rich sources of driver oncogenes, but reconstructing these from sequencing data is a challenge. Two new studies shed light on the diversity and importance of the SV landscape in cancer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Signatures of complex rearrangements.

References

  1. Dubois, F., Sidiropoulos, N., Weischenfeldt, J. & Beroukhim, R. Nat. Rev. Cancer https://doi.org/10.1038/s41568-022-00488-9 (2022).

  2. Turner, K. M. et al. Nature 543, 122–125 (2017).

    Article  CAS  Google Scholar 

  3. Wu, S. et al. Nature 575, 699–703 (2019).

    Article  CAS  Google Scholar 

  4. Hadi, K. et al. Cell 183, 197–210.e32 (2020).

    Article  CAS  Google Scholar 

  5. Cortes-Ciriano, I., Gulhan, D. C., Lee, J. J.-K., Melloni, G. E. M. & Park, P. J. Nat. Rev. Genet. 23, 298–314 (2022).

    Article  CAS  Google Scholar 

  6. Li, Y. et al. Nature 578, 112–121 (2020).

    Article  CAS  Google Scholar 

  7. Drews, R. M. Nature 606, 976–983 (2022).

    Article  CAS  Google Scholar 

  8. Steele, C. D. et al. Nature 606, 984–991 (2022).

    Article  CAS  Google Scholar 

  9. Dubois, F. P. B. et al. Nat. Cancer https://doi.org/10.1038/s43018-022-00403-z (2022).

    Article  PubMed  Google Scholar 

  10. Bao, L., Zhong, X., Yang, Y. & Yang, L. Nat. Cancer https://doi.org/10.1038/s43018-022-00404-y (2022).

    Article  PubMed  Google Scholar 

  11. Nathanson, D. A. et al. Science 343, 72–76 (2014).

    Article  CAS  Google Scholar 

  12. Hung, K. et al. Nature 600, 731–736 (2021).

    Article  CAS  Google Scholar 

  13. Shoshani, O. et al. Nature 591, 137–141 (2021).

    Article  CAS  Google Scholar 

  14. Ly, P. et al. Nat. Genet. 51, 705–715 (2019).

    Article  CAS  Google Scholar 

  15. Zhang, C.-Z. et al. Nature 522, 179–184 (2015).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Stanford Medicine, Stanford, CA, USA

    Paul S. Mischel

  2. Sarafan ChEM-H, Stanford University, Stanford, CA, USA

    Paul S. Mischel & Vineet Bafna

  3. Cancer Grand Challenges eDyNAmiC team, Cancer Research UK, London, UK

    Paul S. Mischel & Vineet Bafna

  4. Department of Computer Science and Engineering and Halicioglu Data Sciences Institute, University of California, San Diego, La Jolla, CA, USA

    Vineet Bafna

Authors
  1. Paul S. Mischel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vineet Bafna
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Paul S. Mischel or Vineet Bafna.

Ethics declarations

Competing interests

P.S.M. is a co-founder and Scientific Advisory Board member and has equity interest in Boundless Bio. V.B. is a co-founder, consultant and Scientific Advisory Board member and has equity interest in Boundless Bio and Abterra. P.S.M. is team lead of and V.B. is a member of the Cancer Grand Challenges eDyNAmiC team.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mischel, P.S., Bafna, V. Form follows function in cancer genomes. Nat Cancer 3, 905–906 (2022). https://doi.org/10.1038/s43018-022-00428-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s43018-022-00428-4

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer